profile including of the micro biome the hope is that will allow them to identify the drugs and therapies that are more likely to work. those firms are also looking into the benefits of artificial intelligence a digital plaster research arm could in future trigger an alarm if her drugs are no longer having an effect around the clock monitoring costing just a few 100 dollars. lisa schmidt is hoping that personalized medicine could finally provide her with a cure but who has access to all the data that she s giving away. the doctor obviously but now a growing number of companies are also offering these services. established pharmaceutical firms are also having to rethink instead of just. research and treatment options to become service providers.